<p>CARGO Therapeutics（納斯達克代碼：CRGX - 獲取免費報告）在週五發佈的研究報告中被華爾街 Zen 的股票研究人員上調至 “賣出” 評級。</p>
<ul>
<li>2024 年 IPO 觀察：哪些新股票將上市？</li>
</ul>
<p>另外，傑富瑞金融集團在 7 月 8 日的報告中將 CARGO Therapeutics 的目標價格從 3.70 美元上調至 5.00 美元，並給予該股票 “持有” 評級。六位分析師對該股票給予了 “持有” 評級，一位分析師給予了 “賣出” 評級。根據 MarketBeat 的數據，CARGO Therapeutics 的共識評級為 “減持”，平均目標價格為 15.40 美元。</p>
<p>獲取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
<p><strong>查看我們關於 CARGO Therapeutics 的最新股票報告</strong></p>
<h2>CARGO Therapeutics 價格表現</h2>
<p>CRGX 股票在週五開盤價為 4.47 美元。該股票的 50 日移動平均價為 4.44 美元，200 日移動平均價為 4.23 美元。CARGO Therapeutics 的 52 周最低價為 3.00 美元，52 周最高價為 25.45 美元。該公司的市值為 2.1617 億美元，市盈率為-0.96，貝塔值為 0.30。</p>
<h2>對 CARGO Therapeutics 的對沖基金看法</h2>
<p>機構投資者和對沖基金最近調整了對該股票的持有。Ascent Group LLC 在第一季度購買了 CARGO Therapeutics 的新頭寸，價值 43,000 美元。Jane Street Group LLC 在第二季度購買了 CARGO Therapeutics 的新頭寸，價值 45,000 美元。XTX Topco Ltd 在第一季度購買了 CARGO Therapeutics 的新頭寸，價值 46,000 美元。Brooklyn Investment Group 在第一季度將其在 CARGO Therapeutics 的持股增加了 512.3%。Brooklyn Investment Group 現在擁有 11,328 股該公司的股票，價值 46,000 美元，此前在上個季度又增持了 9,478 股。最後，洛杉磯資本管理公司在第二季度購買了 CARGO Therapeutics 的新頭寸，價值 46,000 美元。目前 93.16% 的股票由機構投資者持有。</p>
<h2>關於 CARGO Therapeutics</h2>
<p>（獲取免費報告）</p>
<p>CARGO Therapeutics, Inc 是一家臨牀階段的生物技術公司，開發用於癌症患者的嵌合抗原受體（CAR）T 細胞療法。該公司的主要項目是 CRG-022，一種自體 CD22 CAR T 細胞產品候選藥物，旨在通過靶向 CD22 這一在 B 細胞惡性腫瘤中表達的替代腫瘤抗原來應對耐藥機制。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 CARGO Therapeutics</li>
<li>現在值得購買的三隻巨頭成長股</li>
<li>皇家加勒比的收益超出預期，推動 2025 年強勁前景</li>
<li>什麼是低市盈率，它對投資者意味着什麼？</li>
<li>Alphabet 的突破潛力：從落後者到 AI 領導者</li>
<li>股息貴族名單中的最佳：通過貴族指數積累財富</li>
<li>TJX 股票價格創下新高，預示着更多新高將隨之而來</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 CARGO Therapeutics 嗎？</h2>
<p>在考慮 CARGO Therapeutics 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 CARGO Therapeutics 並不在名單上。</p>
<p>雖然 CARGO Therapeutics 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CRGX

<p>Wall Street Zen 最近在一份研究報告中將 CARGO Therapeutics (NASDAQ:CRGX) 的評級上調至 “賣出”。Jefferies Financial Group 也將該股票的目標價從 3.70 美元上調至 5.00 美元，並維持 “持有” 評級。目前，CARGO Therapeutics 的共識評級為 “減持”，平均目標價為 15.40 美元。該股票開盤價為 4.47 美元，市值為 2.1617 億美元。機構投資者持有該股票的 93.16%，顯示出對公司的強烈興趣</p>

<p>CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) was upgraded by equities researchers at Wall Street Zen to a &#34;sell&#34; rating in a research report issued on Friday.</p>
<div class="lb-trans"><p>CARGO Therapeutics（納斯達克代碼：CRGX - 獲取免費報告）在週五發佈的研究報告中被華爾街 Zen 的股票研究人員上調至 “賣出” 評級。</p>
</div><ul>
<li>IPO watch 2024: Which new stocks will hit the market?</li>
</ul>
<div class="lb-trans"><ul>
<li>2024 年 IPO 觀察：哪些新股票將上市？</li>
</ul>
</div><p>Separately, Jefferies Financial Group increased their price objective on CARGO Therapeutics from $3.70 to $5.00 and gave the stock a &#34;hold&#34; rating in a report on Tuesday, July 8th. Six analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, CARGO Therapeutics has a consensus rating of &#34;Reduce&#34; and an average price target of $15.40.</p>
<div class="lb-trans"><p>另外，傑富瑞金融集團在 7 月 8 日的報告中將 CARGO Therapeutics 的目標價格從 3.70 美元上調至 5.00 美元，並給予該股票 “持有” 評級。六位分析師對該股票給予了 “持有” 評級，一位分析師給予了 “賣出” 評級。根據 MarketBeat 的數據，CARGO Therapeutics 的共識評級為 “減持”，平均目標價格為 15.40 美元。</p>
</div><p>Get <strong>CARGO Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
</div><p><strong>Check Out Our Latest Stock Report on CARGO Therapeutics</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CARGO Therapeutics 的最新股票報告</strong></p>
</div><h2>CARGO Therapeutics Price Performance</h2>
<div class="lb-trans"><h2>CARGO Therapeutics 價格表現</h2>
</div><p>Shares of CRGX stock opened at $4.47 on Friday. The stock has a fifty day moving average of $4.44 and a 200 day moving average of $4.23. CARGO Therapeutics has a 52 week low of $3.00 and a 52 week high of $25.45. The firm has a market capitalization of $216.17 million, a price-to-earnings ratio of -0.96 and a beta of 0.30.</p>
<div class="lb-trans"><p>CRGX 股票在週五開盤價為 4.47 美元。該股票的 50 日移動平均價為 4.44 美元，200 日移動平均價為 4.23 美元。CARGO Therapeutics 的 52 周最低價為 3.00 美元，52 周最高價為 25.45 美元。該公司的市值為 2.1617 億美元，市盈率為-0.96，貝塔值為 0.30。</p>
</div><h2>Hedge Funds Weigh In On CARGO Therapeutics</h2>
<div class="lb-trans"><h2>對 CARGO Therapeutics 的對沖基金看法</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Ascent Group LLC bought a new position in shares of CARGO Therapeutics during the first quarter valued at $43,000. Jane Street Group LLC bought a new position in shares of CARGO Therapeutics during the second quarter valued at $45,000. XTX Topco Ltd bought a new position in shares of CARGO Therapeutics during the first quarter valued at $46,000. Brooklyn Investment Group increased its holdings in shares of CARGO Therapeutics by 512.3% during the first quarter. Brooklyn Investment Group now owns 11,328 shares of the company's stock valued at $46,000 after acquiring an additional 9,478 shares in the last quarter. Finally, Los Angeles Capital Management LLC bought a new position in shares of CARGO Therapeutics during the second quarter valued at $46,000. 93.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近調整了對該股票的持有。Ascent Group LLC 在第一季度購買了 CARGO Therapeutics 的新頭寸，價值 43,000 美元。Jane Street Group LLC 在第二季度購買了 CARGO Therapeutics 的新頭寸，價值 45,000 美元。XTX Topco Ltd 在第一季度購買了 CARGO Therapeutics 的新頭寸，價值 46,000 美元。Brooklyn Investment Group 在第一季度將其在 CARGO Therapeutics 的持股增加了 512.3%。Brooklyn Investment Group 現在擁有 11,328 股該公司的股票，價值 46,000 美元，此前在上個季度又增持了 9,478 股。最後，洛杉磯資本管理公司在第二季度購買了 CARGO Therapeutics 的新頭寸，價值 46,000 美元。目前 93.16% 的股票由機構投資者持有。</p>
</div><h2>About CARGO Therapeutics</h2>
<div class="lb-trans"><h2>關於 CARGO Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>CARGO Therapeutics, Inc, a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies.</p>
<div class="lb-trans"><p>CARGO Therapeutics, Inc 是一家臨牀階段的生物技術公司，開發用於癌症患者的嵌合抗原受體（CAR）T 細胞療法。該公司的主要項目是 CRG-022，一種自體 CD22 CAR T 細胞產品候選藥物，旨在通過靶向 CD22 這一在 B 細胞惡性腫瘤中表達的替代腫瘤抗原來應對耐藥機制。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than CARGO Therapeutics</li>
<li>3 Monster Growth Stocks to Buy Now</li>
<li>Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>Alphabet’s Breakout Potential: From Laggard to AI Leader</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>TJX Stock Price Hits Fresh High, Signals More Highs to Follow</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 CARGO Therapeutics</li>
<li>現在值得購買的三隻巨頭成長股</li>
<li>皇家加勒比的收益超出預期，推動 2025 年強勁前景</li>
<li>什麼是低市盈率，它對投資者意味着什麼？</li>
<li>Alphabet 的突破潛力：從落後者到 AI 領導者</li>
<li>股息貴族名單中的最佳：通過貴族指數積累財富</li>
<li>TJX 股票價格創下新高，預示着更多新高將隨之而來</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CRGX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CARGO Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 CARGO Therapeutics 嗎？</h2>
</div><p>Before you consider CARGO Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 CARGO Therapeutics 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CARGO Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 CARGO Therapeutics 並不在名單上。</p>
</div><p>While CARGO Therapeutics currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CARGO Therapeutics 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

華爾街禪將 CARGO Therapeutics（NASDAQ:CRGX）的評級上調至賣出